An S - Search Results

1

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis.

Jung K, Choi JS, Koo BM, Kim YJ, Song JY, Sung M, Chang ES, Noh KW, An S, Lee MS, Song K, Lee H, Kim RN, Shin YK, Oh DY, Choi YL. Jung K, et al. Among authors: an s. Cancer Res Treat. 2021 Jan;53(1):9-24. doi: 10.4143/crt.2020.434. Epub 2020 Sep 16. Cancer Res Treat. 2021. PMID: 32972043 Free PMC article.

2

Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.

Lee MS, An S, Song JY, Sung M, Jung K, Chang ES, Choi J, Oh DY, Jeon YK, Yang H, Lakshmi C, Park S, Han J, Lee SH, Choi YL. Lee MS, et al. Among authors: an s. Cancer Res Treat. 2023 Apr;55(2):452-467. doi: 10.4143/crt.2022.910. Epub 2022 Oct 14. Cancer Res Treat. 2023. PMID: 36265509 Free PMC article.

3

Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients.

Lee MS, Jung EA, An SB, Kim YJ, Oh DY, Song JY, Um SW, Han J, Choi YL. Lee MS, et al. Cancer Res Treat. 2017 Oct;49(4):1065-1076. doi: 10.4143/crt.2016.347. Epub 2017 Jan 25. Cancer Res Treat. 2017. PMID: 28161936 Free PMC article.

4

Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.

Noh KW, Lee MS, Lee SE, Song JY, Shin HT, Kim YJ, Oh DY, Jung K, Sung M, Kim M, An S, Han J, Shim YM, Zo JI, Kim J, Park WY, Lee SH, Choi YL. Noh KW, et al. Among authors: an s. J Pathol. 2017 Nov;243(3):307-319. doi: 10.1002/path.4950. Epub 2017 Sep 28. J Pathol. 2017. PMID: 28741662

5

Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC.

Noh KW, Sohn I, Song JY, Shin HT, Kim YJ, Jung K, Sung M, Kim M, An S, Han J, Lee SH, Lee MS, Choi YL. Noh KW, et al. Among authors: an s. Clin Cancer Res. 2018 Sep 1;24(17):4162-4174. doi: 10.1158/1078-0432.CCR-17-3492. Epub 2018 May 18. Clin Cancer Res. 2018. PMID: 29776956

6

Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing.

An S, Koh HH, Chang ES, Choi J, Song JY, Lee MS, Choi YL. An S, et al. Front Oncol. 2022 Aug 10;12:892918. doi: 10.3389/fonc.2022.892918. eCollection 2022. Front Oncol. 2022. PMID: 36033527 Free PMC article.

7

Molecular changes in solitary fibrous tumor progression.

Park HK, Yu DB, Sung M, Oh E, Kim M, Song JY, Lee MS, Jung K, Noh KW, An S, Song K, Nam DH, Kim YJ, Choi YL. Park HK, et al. Among authors: an s. J Mol Med (Berl). 2019 Oct;97(10):1413-1425. doi: 10.1007/s00109-019-01815-8. Epub 2019 Jul 18. J Mol Med (Berl). 2019. PMID: 31321477 Free PMC article.

8

NTRK Fusions in 1113 Solid Tumors in a Single Institution.

Bang H, Lee MS, Sung M, Choi J, An S, Kim SH, Lee SE, Choi YL. Bang H, et al. Among authors: an s. Diagnostics (Basel). 2022 Jun 13;12(6):1450. doi: 10.3390/diagnostics12061450. Diagnostics (Basel). 2022. PMID: 35741260 Free PMC article.

9

NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.

Kim JH, Hong JH, Choi YL, Lee JA, Seo MK, Lee MS, An SB, Sung MJ, Cho NY, Kim SS, Shin YK, Kim S, Kang GH. Kim JH, et al. Among authors: an sb. J Pathol. 2021 Dec;255(4):399-411. doi: 10.1002/path.5779. Epub 2021 Sep 23. J Pathol. 2021. PMID: 34402529

10

Current concepts of neurofibromatosis type 1: pathophysiology and treatment.

Choi J, An S, Lim SY. Choi J, et al. Among authors: an s. Arch Craniofac Surg. 2022 Feb;23(1):6-16. doi: 10.7181/acfs.2022.00633. Epub 2022 Feb 20. Arch Craniofac Surg. 2022. PMID: 35255591 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,326 results

Search Page

Filters